Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02444637
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- National Neuroscience Institute
- Registry
-
NCT02444637
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Singapore
- Registry status
- Completed
Technical summary
Registry record NCT02444637. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2019-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
- Condition
- Alzheimer Disease
- Condition
- CVA (Cerebrovascular Accident)
- Intervention (Drug)
- Rivastigmine
- Lead sponsor
- National Neuroscience Institute
Record details
- Record id
cardio:ct-nct02444637- Content hash
cb18e5715827a5729f3e0200defba243b64cd3e3293f85dc698ac9befbf38acb